Frontlight ResearchEarly access
CompletedNo phase
Microporous Polysaccharide Hemospheres (MPH) Improving Outcome After Rectal Surgery
Key facts
- Who runs it
- Grupo Español de Rehabilitación Multimodal
- Where
- Spain5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 130 people enrolled
- Started
- 1 Apr 2021
- Ended
- 30 Jun 2024
- Type of study
- Observational
- Treatments tested
- microporous polysaccharide hemospheres (MPH) agent in rectal surgery
- Record updated
- 16 July 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- All adult patients (aged >18 years) with a diagnosis of malignant rectal cancer who are scheduled for radical surgery (anterior resection). Informed consent will be obtained from all subjects, who will participate in the study voluntarily
Who cannot take part
- Patient refusal, patients undergoing emergency surgery, patients under 18 years of age, existence of other concomitant surgical processes. Previous chemo-radiotherapy. Ileostomy or colostomy. Patients that have receive a drain
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Multi-center, prospective, cohort study, of patients scheduled for elective rectal surgery who received absorbable hemostatic powder to assess whether it can improve patient postoperative outcomes, reduce usage of drains and prove to be cost-effective. This cohort will be compared to a previously studied cohort using drains (Power and IMPRICA study) with comparable patient characteristics.
Read full original descriptionShow less
The primary endpoint of the study is: postoperative pelvic sepsis within 60 postoperative days including anastomotic leakage, pelvic abscess and peritonitis.
Secondary endpoints: postoperative morbidities, rate of reoperation and length of hospitalization.
Treatments tested
- microporous polysaccharide hemospheres (MPH) agent in rectal surgery
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of Microporous Polysaccharide Hemospheres (MPH) Agent in Preventing Postoperative Complications After Rectal Surgery (EPHAS Study).
- Record updated
- 16 July 2024